Monthly Archives: January 2017

SUPREME COURT RULES APPROVAL OF PARLIAMENT NEEDED TO TRIGGER ARTICLE 50

The post below was first published on our Litigation blog In a landmark constitutional law ruling, the Supreme Court today held (by a majority of 8 to 3) that the UK Government cannot trigger Article 50 of the Treaty on the European … Continue reading

Leave a Comment

Filed under Article 50, Disputes

SUPREME COURT RULES THAT THE APPROVAL OF PARLIAMENT IS REQUIRED TO TRIGGER ARTICLE 50

In a landmark constitutional law ruling (R (Miller) v Secretary of State for Exiting the EU [2017] UKSC 5, the Supreme Court today held (by a majority of 8 to 3) that the UK Government cannot trigger Article 50 of … Continue reading

Leave a Comment

Filed under Article 50

PATENT AND PHARMA UPDATE, JANUARY 2017

The post below was first published on our Intellectual Property blog Our regular patent and pharma update aims to keep you informed of recent developments in United Kingdom and European law relating to patents and the pharmaceutical industry.

Leave a Comment

Filed under Intellectual property, Pharma, TMT

BREXIT – WHAT IP ISSUES TO CONSIDER NOW

The post below was first published on our Intellectual Property blog We set out our thoughts and predictions upon how protection and enforcement of IP in the UK may be impacted once Brexit arrives. We have also suggested some immediate action points … Continue reading

Leave a Comment

Filed under Consumer, Data protection, Intellectual property, Pharma, TMT